Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Gynecologic 1Breast 1

Conditions

Prostatic Neoplasms 10Kidney Neoplasms 2Carcinoma, Renal Cell 2Ovarian Neoplasms 1Inflammation 1Endometriosis 1Cardiovascular Diseases 1Breast Neoplasms 1Advanced Renal Cell Carcinoma (RCC) 1

Interventions

aldesleukin 43Sunitinib 42Cyclophosphamide 30Nivolumab 29pembrolizumab 27Everolimus 27Interferon-alpha 25Bevacizumab 23Sorafenib 22Interleukin-2 20fludarabine phosphate 19Radiotherapy 18Ipilimumab 18Filgrastim 18Axitinib 18Gene Expression Profiling 16Peripheral Blood Stem Cell Transplantation 15Gemcitabine 15cabozantinib 14Radiosurgery 13fludarabine 11Doxorubicin 11Carboplatin 11Blood Specimen Collection 11temsirolimus 10atezolizumab 9Immunohistochemistry 9Etoposide 9Chemotherapy, Adjuvant 9sargramostim 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Kidney Neoplasms × Atorvastatin × Genitourinary × Clear all
NCT05796973 2025-06-27

MOVES

Tampere University Hospital

Phase 3 Recruiting
240 enrolled
BreastGenitourinaryGynecologic

Breast Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT00490698 2013-03-18

Zoledronate With Atorvastatin in Renal Cell Carcinoma

M.D. Anderson Cancer Center

Phase 2 Completed
11 enrolled 5 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡